Idiopathic achalasia

Idiopathic achalasia is a rare primary esophageal motility disorder characterized by the failure of the lower esophageal sphincter (LES) to relax properly during swallowing, combined with absent or abnormal peristalsis (coordinated muscle contractions) of the esophageal body. The condition results from the progressive degeneration and loss of inhibitory ganglion cells in the myenteric (Auerbach's) plexus of the esophageal wall, though the exact cause of this neuronal loss remains unknown — hence the term 'idiopathic.' The disease primarily affects the gastrointestinal system, specifically the esophagus, leading to functional obstruction at the gastroesophageal junction. The hallmark symptoms include progressive dysphagia (difficulty swallowing) for both solids and liquids, regurgitation of undigested food, chest pain, weight loss, and sometimes nocturnal coughing or aspiration. Patients may also experience heartburn-like symptoms that do not respond to acid-suppressing medications. Over time, the esophagus may become significantly dilated (megaesophagus) due to chronic obstruction. The diagnosis is typically confirmed through esophageal manometry, which demonstrates impaired LES relaxation and absent peristalsis, along with barium swallow studies showing the characteristic 'bird's beak' narrowing at the gastroesophageal junction. Treatment options aim to reduce the pressure at the LES to facilitate esophageal emptying. First-line therapies include pneumatic dilation (balloon stretching of the LES) and surgical myotomy (Heller myotomy), which involves cutting the muscle fibers of the LES, often performed laparoscopically with an anti-reflux procedure. Peroral endoscopic myotomy (POEM) has emerged as an effective minimally invasive alternative. Pharmacological treatments such as calcium channel blockers or nitrates, and botulinum toxin injection into the LES, may provide temporary relief but are generally reserved for patients who are not candidates for more definitive interventions. Achalasia is a chronic condition, and while treatments can significantly improve symptoms, they do not restore normal esophageal motility. Long-standing achalasia is associated with a slightly increased risk of esophageal squamous cell carcinoma, warranting long-term surveillance.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Idiopathic achalasia